A step-by-step guide to creating market success.
Success factors related to conducting basket LTFU studies.
The value of digital health technologies in supporting drug reimbursement decisions
Expertise in mission-critical pricing, market access, and reimbursement.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.
In the fall of 2020, the European Commission issued a proposal to modify the implementation timeline for the new In Vitro Diagnostic Medical Devices Regulation (IVDR). Now, as of 15 December 2021, the European Parliament and the European Council have adopted this proposal, making the suggested progressive IVDR rollout timeline official.